Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

Research output: Contribution to journalArticle (Academic Journal)peer-review

Original languageEnglish
Article numbere1002248
JournalPLoS Medicine
Volume14
Issue number2
DOIs
Publication statusPublished - 28 Feb 2017

Cite this